Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Myokymia

  • Author: Suying L Song, MD; Chief Editor: Nicholas Lorenzo, MD, MHA, CPE  more...
 
Updated: Nov 12, 2014
 

Background

Myokymia, a form of involuntary muscular movement, usually can be visualized on the skin as vermicular or continuous rippling movements.

The word myokymia was used first more than 100 years ago, when Schultze described continuous, slow, undulating muscular contractions in small muscles of hands and feet.[1] Kny used the term myoclonus fibrillaris multiplex to describe similar clinical manifestations.[2] For the past century, different authors applied the term myokymia to different involuntary muscular movements. Most of them showed electromyographic (EMG) evidence of spontaneous group discharges. This led to tremendous confusion in conceptually defining this particular clinical entity and its electrophysiologic features.

Next

Pathophysiology

The clinical phenomenon is characterized by its classic quivering movement of the involved muscle without movement of the joint. Myokymia can be seen in muscles innervated by cranial or spinal nerves. The distribution can be either regional or generalized, depending on the etiology. Also, it can be seen transiently in healthy subjects after strenuous exercise.

The exact mechanism(s) of myokymia is not well understood. Myokymia of the facial muscles is believed to originate from the facial nucleus or from some contribution by a supranucleus process; however, the presence of myokymia in polyradiculopathy indicates the possibility of a more distal generator. Most authors agree that myokymia in other parts of the body is generated by distal motor axons, either by a primarily axonal process or by segmental demyelination with secondary axonal dysfunction. Some have postulated that transaxonal ephaptic excitation occurs peripherally after focal nerve damage leads to formation of an artificial synapse.

Myokymia is believed to be associated with generation of spontaneous activity, including myokymialike discharge in the dystrophic mouse whose nerve root axons have no Schwann-cell enwrapment. By this mechanism, spontaneous discharge could initiate volleys of activity or afferent fibers could directly stimulate efferent fibers in the vicinity of the lesion and produce a self-perpetuating reverberating circuit.

The central nervous system's electrotonic spread of discharge from rhythmic generators toward anterior horn cells also might play a role in generation of the spontaneous discharge. Each patient may have a different operating mechanism, depending on the particular areas involved and the different etiologies. The fact that patients with Isaacs syndrome respond dramatically to treatment of myokymia with phenytoin and/or carbamazepine[3] suggests a possible abnormality of the potassium channel in this particular entity.

Previous
Next

Epidemiology

Frequency

United States

Although myokymia can be seen in patients with different neurological and medical conditions and occasionally even in healthy subjects, it is a relatively rare clinical manifestation.

Mortality/Morbidity

See the list below:

  • Most of the diseases associated with myokymia are not life threatening.
  • The prognosis is solely dependent upon the underlying etiologies.
  • Myokymia is considered benign when detected in patients after strenuous exercise.
Previous
 
 
Contributor Information and Disclosures
Author

Suying L Song, MD Assistant Clinical Professor of Neurology, New York University School of Medicine

Suying L Song, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Neil A Busis, MD Chief of Neurology and Director of Neurodagnostic Laboratory, UPMC Shadyside; Clinical Professor of Neurology and Director of Community Neurology, Department of Neurology, University of Pittsburgh Physicians

Neil A Busis, MD is a member of the following medical societies: American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine

Disclosure: Nothing to disclose.

Chief Editor

Nicholas Lorenzo, MD, MHA, CPE Founding Editor-in-Chief, eMedicine Neurology; Founder and CEO/CMO, PHLT Consultants; Chief Medical Officer, MeMD Inc

Nicholas Lorenzo, MD, MHA, CPE is a member of the following medical societies: Alpha Omega Alpha, American Association for Physician Leadership, American Academy of Neurology

Disclosure: Nothing to disclose.

Additional Contributors

Carmel Armon, MD, MSc, MHS Chair, Department of Neurology, Assaf Harofeh Medical Center, Tel Aviv University Sackler Faculty of Medicine, Israel

Carmel Armon, MD, MSc, MHS is a member of the following medical societies: American Academy of Neurology, Massachusetts Medical Society, American Academy of Sleep Medicine, American Stroke Association, American Association of Neuromuscular and Electrodiagnostic Medicine, American Clinical Neurophysiology Society, American College of Physicians, American Epilepsy Society, American Medical Association, American Neurological Association, Sigma Xi

Disclosure: Received research grant from: Neuronix Ltd, Yoqnea'm, Israel.

References
  1. Schultze F. Beitrage zur Muskelpathologie. Deutsch Z Nervenheilk. 1895. 6:65-167.

  2. Kny E. Ueber ein dem Paramyoclonus multiplex (Friedreich) nahestehendes Krankheitsbild. Arch Psychiat Nervenkr. 1888. 19:577.

  3. Jackson DL, Satya-Murti S, Davis L, Drachman DB. Isaacs syndrome with laryngeal involvement: an unusual presentation of myokymia. Neurology. 1979 Dec. 29(12):1612-5. [Medline].

  4. Isaacs H. A syndrome of continuous muscle-fibre activity. J Neurol Neurosurg Psychiat. 1961. 24:319-325.

  5. Doi H, Arimura K, Ohyagi Y, Kira J. Frostbite-like skin lesion as an autonomic symptom of Isaacs' syndrome. Intern Med. 2011. 50(10):1113-5. [Medline].

  6. Hayashi Y, Kimura A, Watanabe N, Yamada M, Sakurai T, Tanaka Y, et al. Serial monitoring of basal metabolic rate for therapeutic evaluation in an Isaacs' syndrome patient with chronic fluctuating symptoms. Intern Med. 2010. 49(5):475-7. [Medline].

  7. Lide B, Singh J, Haeri S. Isaacs' syndrome in pregnancy. BMJ Case Rep. 2014 Oct 9. 2014:[Medline].

  8. Daube JR, Kelly JJ, Martin RA. Facial myokymia with polyradiculoneuropathy. Neurology. 1979 May. 29(5):662-9. [Medline].

  9. Moghimi N, Rosen JB, Jabbari B. Ten Years' Follow-Up of a Family With Myokymia and Muscle Cramps Without Ataxia. J Child Neurol. 2013 Nov. 28(11):1493-1495. [Medline].

  10. Alapati A, Glaussen G, Oh SJ. Myokymia as an initial and predominant manifestation of dermatomyositis. AAEM Abstracts. 1999. 95.

  11. Albers JW, Allen AA, Bastron JA, Daube JR. Limb myokymia. Muscle Nerve. 1981 Nov-Dec. 4(6):494-504. [Medline].

  12. Andermann F, Cosgrove J, Lloyd-Smith DL. Facial myokymia in multiple sclerosis. Brain. 1961. 84:31-44.

  13. Blunt SB, Khalil NM, Perkin GD. Facial myokymia in multiple system atrophy. Mov Disord. 1997 Mar. 12(2):235-8. [Medline].

  14. Brick JF, Gutmann L, McComas CF. Calcium effect on generation and amplification of myokymic discharges. Neurology. 1982 Jun. 32(6):618-22. [Medline].

  15. Chinskey ND, Cornblath WT. Inferior oblique myokymia: a unique ocular motility disorder. JAMA Ophthalmol. 2013 Mar. 131(3):404-5. [Medline].

  16. Denny-Brown D, Foley JM. Myokymia and the benign fasciculation of muscular cramps. Trans Assoc Am Physicians. 1948. 61:88-96.

  17. Fernandez M, Raskind W, Wolff J, Matsushita M, Yuen E, Graf W. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder. Ann Neurol. 2001 Apr. 49(4):486-92. [Medline].

  18. Gardner-Medwin D, Walton JN. Myokymia with impaired muscular relaxation. Lancet. 1969 Jan 18. 1(7586):127-30. [Medline].

  19. Greenhouse AH, Bicknell JM, Pesch RN, Seelinger DF. Myotonia, myokymia, hyperhidrois and wasting of muscle. Neurology. 1967 Mar. 17(3):263-8. [Medline].

  20. Gutmann L, Gutmann L. Myokymia and neuromyotonia 2004. J Neurol. 2004 Feb. 251(2):138-42. [Medline].

  21. Hudson AJ, Brown WF, Gilbert JJ. The muscular pain-fasciculation syndrome. Neurology. 1978 Nov. 28(11):1105-9. [Medline].

  22. Isaacs H. Continuous muscle fibre activity in an Indian male with additional evidence of terminal motor fibre abnormality. J Neurol Neurosurg Psychiatry. 1967 Apr. 30(2):126-33. [Medline].

  23. Isaacs H, Frere G. Syndrome of continuous muscle fibre activity. Histochemical, nerve terminal and end-plate study of two cases. S Afr Med J. 1974 Aug 10. 48(38):1601-7. [Medline].

  24. Lance JW, Burke D, Pollard J. Hyperexcitability of motor and sensory neurons in neuromyotonia. Ann Neurol. 1979 Jun. 5(6):523-32. [Medline].

  25. Lublin FD, Tsairis P, Streletz LJ, et al. Myokymia and impaired muscular relaxation with continuous motor unit activity. J Neurol Neurosurg Psychiatry. 1979 Jun. 42(6):557-62. [Medline].

  26. Lutschg J, Jerusalem F, Ludin HP, et al. The syndrome of 'continuous muscle fiber activity.'. Arch Neurol. 1978 Apr. 35(4):198-205. [Medline].

  27. Matthews WB. Facial myokymia. J Neurol Neurosurg Psychiatry. 1966 Feb. 29(1):35-9. [Medline].

  28. Medina JL, Chokroverty S, Reyes M. Localized myokymia caused by peripheral nerve injury. Arch Neurol. 1976 Aug. 33(8):587-8. [Medline].

  29. Parry-Jones NO, Stephens JA, Taylor A, Yates DA. Myokymia, not myotonia. Br Med J. 1977 Jul 30. 2(6082):300. [Medline].

  30. Roth G. The origin of fasciculations. Ann Neurol. 1982 Dec. 12(6):542-7. [Medline].

  31. Solimena M, Folli F, Denis-Donini S, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med. 1988 Apr 21. 318(16):1012-20. [Medline].

  32. Valenstein E, Watson RT, Parker JL. Myokymia, muscle hypertrophy and percussion "myotonia" in chronic recurrent polyneuropathy. Neurology. 1978 Nov. 28(11):1130-4. [Medline].

  33. Wallis WE, Van Poznak A, Plum F. Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin. Arch Neurol. 1970 May. 22(5):430-9. [Medline].

  34. Welch LK, Appenzeller O, Bicknell JM. Peripheral neuropathy with myokymia, sustained muscular contraction, and continuous motor unit activity. Neurology. 1972 Feb. 22(2):161-9. [Medline].

  35. Williamson E, Brooke MH. Myokymia and the motor unit. A histochemical study. Arch Neurol. 1972 Jan. 26(1):11-6. [Medline].

 
Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.